Partnership with pharmacy matters: Novo Nordisk
Novo Nordisk is rolling out a host of primary care tools to support pharmacy’s diabetes patients; identify people who may not have been diagnosed; and reduce the rates of people …
Gaviscon teams up with pharmacist bartender
To help pharmacists ‘visualise’ the acid pocket concept and Gaviscon mode of action, RB teamed up with an expert bartender and community pharmacist Stuart Nankivell to create a short educational …
Have you completed your Nuromol product training on RB HealthHub yet?
RB’s competition with Adriano Zumbo closes on Monday 31 August, and this is your last chance to enter! All you have to do is complete your Nuromol® product training module …
GBMA welcomes the ‘a’ flagging of biosimilar infliximab
The Generic and Biosimilar Medicines Association has welcomes the recommendation by the PBAC to list biosimilar infliximab (Inflectra) on the PBS and to recommend the marking as equivalent, also known …
There’s still time to register for PA2015!
In a few weeks, hundreds of pharmacy assistants will make their way to the Gold Coast for the annual Pharmacy Assistant National Conference (PA2015); allowing them to attend can be …
‘A’ flagging has Medicines Australia concerned
Medicines Australia has expressed concern about the PBAC’s recommendation that pharmacists be allowed to substitute the biosimilars in place of biologic medicines prescribed by a patient’s doctor. “The so-called ‘a-flagging’ …
Government must act on new hepatitis C meds, says peak body
The Federal Government needs to list new hepatitis C medicines on the PBS without further delay, according to the peak body representing the interests of a quarter of a million …
$5 million in grants to Australian research on type 2 diabetes
Three Australian research teams have been awarded grants as part of a global effort to combat the growing incidence of type 2 diabetes, which affects more than 300 million people …
Biosimilars: PBAC ‘a’ flags infliximab
The PBAC today recommended that Inflectra (infliximab), the first monoclonal antibody ‘mAb’ biosimilar registered in Australia, be added to the Pharmaceutical Benefits Scheme. The recommendation is the first step towards …
Long working hours linked to higher risk of stroke
Working more than 55 hours is linked to a huge increased risk of stroke and also coronary heart disease, according to a study published in The Lancet. The study—the largest …
Michael Williams fastest pharmacist at Snow Business
Eltham pharmacist Michael Williams has taken out the title of fastest pharmacist, winning the Medici Capital Pharmacy Ski Race for 2015. The annual race was held at Mt Buller this …
Clinical tips: men and cancer explained
Sometimes men need to be scared into taking action when they present with pain and other symptoms, writes Karalyn Huxhagen Cancer in males can be in many forms, some of …